Skip to content

Assessment of Ultrasound-guided Inserted Peripheral Intravenous Catheter

A Clinical Assessment of an Ultrasound-guided Inserted Peripheral Intravenous Catheter

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01602133
Acronym
ECLIPSE
Enrollment
29
Registered
2012-05-18
Start date
2012-06-30
Completion date
2014-06-30
Last updated
2012-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous Puncture

Keywords

venous puncture, seldinger technique, ultrasound guidance

Brief summary

Evaluate the safety and efficacy of an an ultrasound-guided inserted peripheral intravenous catheter during a period of seven days.

Interventions

PROCEDUREperipheral venous puncture

Ultrasound imaging of the arm is performed. If a suitable vein is identified, a percutaneous puncture is performed under ultrasound guidance. Then, an intravenous catheter is inserted according Seldinger method.

Sponsors

Prodimed SAS
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Hospitalized patients with need of an intravenous therapy on peripheral line * Unsuccessful attempts at establishing a peripheral intravenous line by nurse * Age over 18 YO * Written informed consent obtained

Exclusion criteria

* pregnant woman * local contra-indication for venous puncture * unconscious patient * need of intravenous therapy requiring central line

Design outcomes

Primary

MeasureTime frame
length of use of the catheter measured in number of daysseven days

Secondary

MeasureTime frameDescription
adverse event during the period of use of the catheterseven daysextravasation and/or catheter removal before the end of the treatment and/or local complications (bleeding, neurologic trouble, venous thrombosis..)

Countries

France

Contacts

Primary Contactpascal meyer, MD
pas.meyer@yahoo.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026